Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer

Urology

Volumn 52, Issue 2, 1998, Pages 224-229

  Tefilli, Marcos V ^b   Gheiler, Edward L ^b   Tiguert, Rabi ^b   Banerjee, Mousumi ^b   Forman, Jeffrey ^b   Pontes, J Edson ^b   Wood Jr , David P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; URINE INCONTINENCE;

FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 0032145380     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00151-4     Document Type: Article

References (30)

1. Zeitman A.L., Coen J.J., Shipley W.U., et al. Radical radiation therapy in the management of prostatic adenocarcinoma the initial prostate specific antigen value as a predictor of treatment outcome . J Urol. 151:1994;640-645.
2. Eggleston J.C., Walsh P.C. Radical prostatectomy with preservation of sexual function pathologic findings in the first 100 cases . J Urol. 134:1985;1146-1148.
3. Catalona W.J., Bigg S.W. Nerve-sparing radical prostatectomy evaluation of results after 250 patients . J Urol. 143:1990;538-544.
4. Partin A.W., Oesterling J.E. The clinical usefulness of prostate specific antigen update 1994 . J Urol. 152:1994;1358-1368.
5. Goad J.R., Chang S.T., Ohori M., et al. PSA after definitive radiotherapy for clinically localized prostate cancer. Urol Clin North Am. 20:1993;727-736.
6. Zincke H., Oesterling J.E., Blute M.L., et al. Long term results after radical prostatectomy for clinically localized prostate cancer. J Urol. 152:1994;1850-1857.
7. Ray G.R., Cassady J.R., Bagshaw M.A. Definitive radiation therapy of carcinoma of the prostate A report on 15 years experience . Radiology. 106:1973;407-418.
8. Harisiadis L., Veenema R.J., Senyszyn J.J., et al. Carcinoma of the prostate treatment with external radiotherapy . Cancer. 41:1978;2131-2142.
9. Forman J.D., Meetze K., Pontes J.E., et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol. 158:1997;1436-1440.
10. Pontes J.E. Role of surgery in managing local recurrence following external-beam radiation therapy. Urol Clin North Am. 21:1994;701-706.
11. Manual for Staging of Cancer. 4th ed. 1992;181-183 JB Lippincott, Philadelphia.
12. Gleason D.F. Histologic grading and staging of prostatic carcinoma. Tannenbaum M. Urologic Pathology The Prostate . 1997;171-179 Lea & Febiger, Philadelphia.
13. Sakr W.A., Grignon D.J., Visscher D.W., et al. Evaluating the radical prostatectomy specimen part I . J Urol Pathol. 3:1995;355-358.
14. Kuban D.A., El-Mahdi A.M., Schellhammer P.F. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;307-316.
15. Stamey T.A., Graves H.C.B., Wehner N., et al. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol. 149:1993;787-792.
16. Partin A.W., Pound C.R., Clemens J.Q., et al. Serum PSA after anatomic radical prostatectomy The Johns Hopkins experience after 10 years . Urol Clin North Am. 20:1993;713-725.
17. Lange P.H., Ercole C.J., Lightner D.J., et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol. 141:1989;873-879.
18. Prestigiacomo A.F., Stamey T.A. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol. 152:1994;1515-1519.
19. Lee W.R., Hanbon A.L., Hanks G.E. Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer the relationship between nadir level and disease-free survival . J Urol. 156:1996;450-453.
20. Stamey T.A., Kabalin J.N., McNeal J.E., et al. Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II. Radical prostatectomy treated patients . J Urol. 141:1989;1076-1083.
21. Vander Kooy M.J., Pisansky T.M., Cha S.S., et al. Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology. 49:1997;65-70.
22. Schild S.E., Buskirk S.J., Wong W.W., et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 156:1996;1725-1729.
23. Kabalin J.N., Hodge K.K., McNeal J.E., et al. Identification of residual cancer in the prostate following radiation therapy role of transrectal ultrasound guided biopsy and prostate specific antigen . J Urol. 142:1989;326-331.
24. Rogers E., Ohori M., Kassabian V.S., et al. Salvage radical prostatectomy outcome measured by serum prostate specific antigen levels . J Urol. 153:1995;104-110.
25. Lerner S.E., Blute M.L., Zincke H. Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol. 154:1995;1103-1109.
26. Mador D.R., Huben R.P., Wajsman Z., et al. Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol. 133:1985;58-60.
27. Scardino P.T., Wheeler T.M. Local control of prostate cancer with radiotherapy frequency and prognostic significance of positive results of postirradiation prostate biopsy . Natl Cancer Inst Monogr. 7:1988;95-103.
28. Gheiler E.L., Tefilli M.V., Tiguert R., et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology. 51:1998;789-795.
29. Partin A.W., Pearson J.D., Landis P.K., et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43:1994;649-659.
30. Cadeddu J.A., Partin A.W., DeWeese T.L., et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 159:1998;173-178.